Back to KROS
WELLS FARGO & COMPANY/MN → KROS
WELLS FARGO & COMPANY/MN KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
9
Latest value
$1.6M
Q3 2026
Peak value
$1.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $667K |
| Q1 2026 | $122K |
| Q1 2026 | $1.5M |
| Q1 2026 | $122K |
| Q1 2026 | $1.5M |
| Q2 2026 | $166K |
| Q2 2026 | $1.5M |
| Q3 2026 | $41K |
| Q3 2026 | $1.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.6M | 140.0K | — | — |
| Q3 2026 | $41K | 3.6K | — | — |
| Q2 2026 | $1.5M | 140.0K | — | — |
| Q2 2026 | $166K | 15.5K | — | — |
| Q1 2026 | $1.5M | 140.0K | — | — |
| Q1 2026 | $122K | 11.0K | — | — |
| Q1 2026 | $1.5M | 140.0K | — | — |
| Q1 2026 | $122K | 11.0K | — | — |
| Q4 2025 | $667K | 32.8K | — | — |